Back to ACAD
ALPS ADVISORS INC ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
5
Latest value
$5M
Q3 2026
Peak value
$5M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $2.1M |
| Q4 2025 | $4.2M |
| Q1 2026 | $3.6M |
| Q2 2026 | $5M |
| Q3 2026 | $5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $5M | 249.4K | — | — |
| Q2 2026 | $5M | 197.0K | — | — |
| Q1 2026 | $3.6M | 162.8K | — | — |
| Q4 2025 | $4.2M | 158.2K | — | — |
| Q3 2025 | $2.1M | 99.8K | — | — |
Other funds holding ACAD
$377M
$322.9M
$302.7M
$247.8M
$229.6M
$229.6M